Currently holds positions in LogicBio Therapeutics Inc, Akebia Therapeutics Inc and ImmunoGen Inc
Position | Company | Period |
---|---|---|
Director | LogicBio Therapeutics Inc | March 17, 2020 - |
Independent Director | Akebia Therapeutics Inc | Dec. 12, 2018 - |
President, Chief Executive Officer, Director | ImmunoGen Inc | May 16, 2016 - |
Independent Director | Keryx Biopharmaceuticals Inc | Sept. 11, 2017 - Dec. 12, 2018 |
Independent Director | Fate Therapeutics Inc | July 1, 2012 - May 2, 2018 |
Director | Proteostasis Therapeutics Inc | June 30, 2014 - Jan. 1, 2015 |
Chief Executive Officer, Director | Proteostasis Therapeutics Inc | None - |
Search
Notification date | Transaction date | B/S Transaction type |
Nb. shares Price Value |
Number of shares | Price | Total value | Details | |
---|---|---|---|---|---|---|---|---|
2024-02-06 | 2024-02-05 |
ImmunoGen Inc
(IMGN)
|
PS Planned sale |
20,107
-3.3%
29.28588,733 USD |
20,107 -3.3% | 29.28 | 588,733 USD | |
2023-08-04 | 2023-08-04 |
ImmunoGen Inc
(IMGN)
|
S Sale |
992,397
-64.2%
16.9616,831,053 USD |
992,397 -64.2% | 16.96 | 16,831,053 USD | |
2023-08-04 | 2023-08-03 |
ImmunoGen Inc
(IMGN)
|
S Sale |
1,020,000
-69.8%
16.6116,942,200 USD |
1,020,000 -69.8% | 16.61 | 16,942,200 USD | |
2023-08-04 | 2023-08-02 |
ImmunoGen Inc
(IMGN)
|
S Sale |
8,636
-1.9%
18.15156,743 USD |
8,636 -1.9% | 18.15 | 156,743 USD | |
2023-08-04 | 2023-08-02 |
ImmunoGen Inc
(IMGN)
|
S Sale |
986,521
-68.7%
17.4517,214,791 USD |
986,521 -68.7% | 17.45 | 17,214,791 USD | |
2020-02-25 | 2020-02-24 |
ImmunoGen Inc
(IMGN)
|
PS Planned sale |
55,222
-11.3%
4.99275,558 USD |
55,222 -11.3% | 4.99 | 275,558 USD | |
2019-02-25 | 2018-02-22 |
ImmunoGen Inc
(IMGN)
|
PS Planned sale |
51,070
-9.5%
5.60285,992 USD |
51,070 -9.5% | 5.60 | 285,992 USD |